Integral Health Asset Management, LLC
Position in TVTX — Travere Therapeutics, Inc.
CIK 1773206
New York, NY
Position in TVTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$21,303,750
+$19,561,750 QoQ
Shares Held
375,000
+275.0% QoQ
Ownership
0.398%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
#51
of 315 holders
Holding Since
Mar 2021
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TVTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Integral Health Asset Management, LLC holds $1,502,601,600 across 54 Biotechnology names. TVTX ranks #15 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
1,500,000 | $280,920,000 | |
| 2 | INSM |
INSMED Inc
|
1,600,000 | $170,592,000 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,600,000 | $136,304,000 | |
| 4 | EWTX |
Edgewise Therapeutics, Inc.
|
2,000,000 | $81,260,000 | |
| 5 | VERA |
Vera Therapeutics, Inc.
|
1,750,000 | $75,092,500 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
300,000 | $73,431,000 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
2,000,000 | $70,780,000 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
550,000 | $61,066,500 |
All Filings in TVTX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,303,750 | 375,000 | Shares | Sole | 2026-08-14 | |
| 2024-12-31 | $1,742,000 | 100,000 | Shares | Sole | 2025-02-14 | |
| 2021-03-31 | $374,550 | 15,000 | Shares | Sole | 2021-05-10 | |
| No filing history on record for this holder in this stock. | ||||||